Rhythm Pharmaceuticals, Inc. Common Stock

RYTM

Healthcare · 113.35 +1.7% today

Isolated · not yet confirmedMarket checked 25 Aug, 15:55 GMT-4

Jodie situation report

Rhythm Pharmaceuticals, Inc. Common Stock's current read is isolated; its market group is not confirming.

The latest filing evidence is available. 0 of 37 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 0 directly disclosed connections are confirming.

What changed

Revenue increased 46.9% versus the comparable filing period.
The operating loss widened by 3.3M.

Company+1.7% todayVolume comparison unavailable

Market group0 of 37 activeBiotechnology · unavailable

Disclosed network0 of 0 confirmingRelationship data unavailable

What would change this read

Reported product revenue rose to $60.1M (up $22.4M, +59% YoY) driven by higher volume sold domestically and internationally.
Personnel costs increased $20.1M (including $7.8M stock-based comp and $12.3M salaries) to support expanded operations and establishment of international commercial operations.

Invalidation: The isolated read changes if RYTM's group or a disclosed connection begins moving with it.

Watch this read

Who this business touches

The relationships behind RYTM

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Filing peers

NBIXGPCRBIOA

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

RYTM is currently a Follower in the organic co-movement group Biotechnology. This group is discovered from market behaviour rather than assigned from an industry taxonomy. No verified filing-linked names are available yet.